Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease

Detalles Bibliográficos
Autores principales: Pontali, Emanuele, Volpi, Stefano, Antonucci, Giancarlo, Castellaneta, Marco, Buzzi, Davide, Tricerri, Francesca, Angelelli, Alessia, Caorsi, Roberta, Feasi, Marcello, Calautti, Francesca, Castagnola, Elio, Rollandi, Gian Andrea, Ravelli, Angelo, Cassola, Giovanni, Gattorno, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211718/
https://www.ncbi.nlm.nih.gov/pubmed/32437739
http://dx.doi.org/10.1016/j.jaci.2020.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211718/
https://www.ncbi.nlm.nih.gov/pubmed/32437739
http://dx.doi.org/10.1016/j.jaci.2020.05.002

Ejemplares similares